TOP TIERMARKET NEWSWIRE
Movers explained · November 20, 2026

Why Is ADARX PHARMACEUTICAL (ADRX) Stock Moving Today?

By the Top Tier Newswire AI Desk · November 13, 2026 at 5:05 AM ET · reviewed against 2 wire stories

ADARX PHARMACEUTICAL (ADRX) is drawing unusual attention today. Our newswire has captured 2 stories on ADRX across 2 sources in the last 36 hours, with AI sentiment reading mixed (avg 47/100).

Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.

Adarx Pharmaceuticals (ADRX) shares rose 12.11% to $14.91, driven by the release of third-quarter financial results and the initiation of coverage by major investment banks. The company reported a narrowed loss per share and increased collaboration revenue, while analysts assigned positive ratings and price targets.

What Happened

Adarx Pharmaceuticals filed a Form 8-K on November 12, 2026, disclosing its third-quarter 2026 results. The company reported a GAAP loss per share of $1.74, a 6% improvement from the $1.85 loss per share recorded in the same period last year. Collaboration revenue increased 43% year over year to $2.2 million.

Two major banks initiated coverage on the stock following the earnings release. TD Cowen initiated coverage with a Buy rating. JP Morgan initiated coverage with an Overweight rating and set a price target of $38. These actions provided fresh institutional perspective on the company’s valuation and growth trajectory.

What The Data Shows

The stock’s market capitalization stands at $1.5 billion. Over the past 52 weeks, the stock traded within a range of $12.50 to $23.21. On November 12, the stock printed 14 fresh 52-week highs and 3 fresh 52-week lows.

Despite the strong session, the stock is down 7.3% over the last eight sessions, moving from $16.09 to $14.91. Insider activity has been notably bullish, with five buys totaling $87.7 million and no sells in the last 90 days. Recent Form 4 filings show purchases by Orbimed Advisors LLC, Gordon Carl L, and Sr One Capital Management, LLC on September 28, 2026.

What To Watch

Investors will monitor how the stock reacts to the new analyst coverage and whether the price target of $38 from JP Morgan influences near-term trading. The upcoming earnings date is not specified in the provided data, so attention remains on the initial market absorption of the third-quarter results and the new institutional ratings.

AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.

ADRX by the numbers

7 sessions: +4.35%Coverage: 2 stories / 2 sourcesAI sentiment: 47/100 (mixed)Mkt cap: $1.5B52w: $12.50 to $23.21
ADRX · Nov 13 session (5-min) · -6.17% vs prior close · updated 8:54 PM ET
$13.86$15.08$16.30prev close $14.91$13.998:35 AM10:30 AM12:25 PM2:20 PM4:15 PM8:35 AM · $15.248:40 AM · $14.669:30 AM · $16.179:40 AM · $14.149:45 AM · $14.759:50 AM · $15.159:55 AM · $14.9310:00 AM · $14.9010:05 AM · $14.6710:10 AM · $14.9710:15 AM · $14.7910:20 AM · $14.9610:25 AM · $14.9510:30 AM · $14.8410:35 AM · $14.9410:40 AM · $14.8810:45 AM · $14.8810:50 AM · $14.8910:55 AM · $14.8811:00 AM · $14.8811:05 AM · $14.8811:10 AM · $14.9511:15 AM · $14.8611:20 AM · $14.9211:25 AM · $14.9611:30 AM · $14.8511:35 AM · $15.2111:40 AM · $14.5311:45 AM · $14.4111:50 AM · $14.6311:55 AM · $14.6312:00 PM · $14.5412:05 PM · $14.4312:10 PM · $14.5412:15 PM · $14.5412:20 PM · $14.4812:25 PM · $14.5212:30 PM · $14.4912:35 PM · $14.6712:40 PM · $15.2112:45 PM · $14.8312:50 PM · $14.6512:55 PM · $14.641:00 PM · $14.521:05 PM · $14.521:10 PM · $14.521:15 PM · $14.521:20 PM · $14.411:25 PM · $14.431:30 PM · $14.541:35 PM · $14.691:40 PM · $14.601:45 PM · $14.591:50 PM · $14.591:55 PM · $14.592:00 PM · $14.542:05 PM · $14.592:10 PM · $14.522:15 PM · $14.522:20 PM · $14.852:30 PM · $14.442:35 PM · $14.432:40 PM · $14.472:45 PM · $14.592:50 PM · $14.702:55 PM · $14.513:00 PM · $14.533:05 PM · $14.523:10 PM · $14.683:15 PM · $14.683:20 PM · $14.613:25 PM · $14.443:30 PM · $14.583:35 PM · $14.573:40 PM · $14.713:45 PM · $14.723:50 PM · $14.193:55 PM · $14.114:00 PM · $14.204:10 PM · $14.014:15 PM · $13.99
AI sentiment, last 36h · averaged over 2 stories · 47/100 neutral
AI sentiment 47/100 (neutral)0 · bearish50bullish · 100

The headlines behind the move

Story flow · 2 stories on the wire, last 36h · hover or tap a dot for the headline
36h ago24h ago12h agonowThe Fly · sentiment 46 · ADARx Pharmaceuticals price target lowered to $36 from $38 at JPMorganThe Fly · 46ADARx Pharmaceuticals price target lowered to $36 from $38 at JPMorganGuruFocus · sentiment 48 · ADRX Maintains Overweight Rating -- Price Target Lowered to $36.00 by JP MorganGuruFocus · 48ADRX Maintains Overweight Rating -- Price Target Lowered to $36.00 by JP Morgan
21h agoGuruFocusNEUTRAL 48Analyst

ADRX Maintains Overweight Rating -- Price Target Lowered to $36.00 by JP Morgan

On October 20, 2026, JP Morgan maintained an "Overweight" rating on Adarx Pharmaceuticals (ADRX). However, the price target has been adjusted down from $38.00 t

1d agoThe FlyNEUTRAL 46Analyst

ADARx Pharmaceuticals price target lowered to $36 from $38 at JPMorgan

Frequently asked questions

Why is ADRX stock moving today?

ADARX PHARMACEUTICAL (ADRX) is drawing unusual attention today. Our newswire has captured 2 stories on ADRX across 2 sources in the last 36 hours, with AI sentiment reading mixed (avg 47/100). The most recent driver: "ADRX Maintains Overweight Rating -- Price Target Lowered to $36.00 by JP Morgan" (GuruFocus).

Is ADRX a buy right now?

Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of ADRX coverage reads 47/100 over 2 stories; treat it as a research signal and do your own diligence.

How fast does this page update?

The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.

More moves explained today

Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →

More on ADRX: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.

Earlier ADRX move explainers: 2026-11-13